Daily news about corporate social responsibility, ethics and sustainability
Tags (5) : rare diseases
Arcera–Fosun Pharma MoU to Boost Global Life Sciences & Neuroscience Innovation
04/28/2026 | Companies
Abu Dhabi,
Alzheimer’s disease,
Arcera Life Sciences,
biologics,
biotechnology,
biotechnology incubation,
cardiometabolic diseases,
cell therapy,
China,
drug development,
emerging markets,
Fosun Pharma,
gene therapy,
global healthcare,
healthcare infrastructure,
innovation,
international collaboration,
joint ventures,
licensing,
life sciences,
market access,
memorandum of understanding,
Middle East healthcare,
MoU,
neurodegenerative diseases,
neuroscience,
oncology,
pharmaceutical industry,
R&D,
radiopharmaceuticals,
rare diseases,
research and development,
siRNA therapies,
small molecules,
strategic partnership,
UAE,
Vision 2030
Jazz Pharmaceuticals Showcases Epilepsy and Narcolepsy Research at AAN 2026
04/09/2026 | Companies
AAN 2026,
American Academy of Neurology,
behavioral symptoms,
cannabidiol,
clinical research,
cognitive function,
Dravet syndrome,
drug development,
DUET study,
EpiCom study,
Epidiolex,
epilepsy,
Jazz Pharmaceuticals,
Lennox-Gastaut syndrome,
medical conference,
narcolepsy,
neurological disorders,
neuroscience,
patient care,
Phase 3 trial,
rare diseases,
refractory epilepsy,
sleep disorders,
treatment outcomes,
tuberous sclerosis complex,
Xywav
Sobi 2025 Annual & Sustainability Report: Advancing Rare Disease Therapies
03/31/2026 | Companies
annual report 2025,
biopharma,
breakthrough medicines,
corporate sustainability,
CSRD,
ESRS,
EU Taxonomy,
global biopharma,
healthcare access,
innovative therapies,
Nasdaq Stockholm,
patient care,
pharmaceutical revenue,
pipeline development,
rare disease treatments,
rare diseases,
scientific expertise,
Sobi,
sustainability report 2025,
Swedish Orphan Biovitrum,
TCFD
Belief BioMed & Grand Life Sciences Partner to Advance Hemophilia A Gene Therapy in China
03/23/2026 | Companies
BBM-H803,
BBM-H901,
Belief BioMed,
biotech industry,
biotechnology partnership,
China healthcare,
clinical development,
commercialization rights,
drug development,
gene therapy,
Grand Life Sciences,
healthcare innovation,
hematology,
hemophilia A,
hemophilia treatment,
innovative therapies,
medical research,
pharmaceutical collaboration,
rare diseases
Companies
Most Popular Now
Environment News
Compliance
Want to write a piece for Daily CSR? Please contact us by email at editor[@]dailycsr.com